Latest News

Could the stock jump by at least 50% by then, or is it already peaking?

A few winners of the tokenization trend are emerging, but it's still the early innings.

Nine of the past 10 times this happened, the stock was up a year later. Is this one different?

Select Water Solutions (NYSE:WTTR) said it has agreed to acquire Pilot Water Solutions for $700 million, expanding its produced-water disposal and pipeline footprint, particularly in the Permian Basin’s Delaware Basin. The transaction is expected to close in the fourth quarter of 2026, subject to cu

The provider of a unified Customer Experience Management (CXM) platform reported a notable insider sale.

Looking over forecasts for the next year, the risk of investing in Netflix may not be worth the reward.

Vanguard S&P 500 ETF (TSX:VFV) is a go-to bet for many Canadians and for good reason.

Genmab A/S (NASDAQ:GMAB) expects a pivotal fourth quarter, with Phase III readouts planned for three late-stage oncology programs that the company views as potential first-in-class opportunities, according to Andrew Carlsen, the company’s vice president and head of investor relations. Carlsen said

Loblaw combines defensive grocery and pharmacy demand with growing earnings, new stores, and a rising dividend.

Too busy to watch the market? These three set-and-forget stocks offer familiar businesses and dividends for a long-term Canadian portfolio.

The platform provider for the grocery industry reported a notable insider stock sale.

Zcash has been a standout performer this year, but its long-term track record is much less impressive.

Bruker (NASDAQ:BRKR) CFO Gerald Herman said the company’s second-quarter results reflected stronger-than-expected organic order bookings and earnings per share, while revenue came in later than anticipated. He attributed the revenue timing primarily to a mixed demand environment and shipment timing,

The insider maintains 462,980 shares worth $29 million after the sale, executed at prices just below market close during a period of strong stock performance.

The market, its dividend payers, and its largest growth stocks -- for about $3 a year in combined fees.

Oklo stock could easily triple if its project pipeline materializes.

Reddit just turned profitable with a new AI licensing revenue stream, while The Trade Desk commands steady growth and stronger cash generation, but their valuations tell opposite stories.

Archer's defense strategy could give it an edge over Joby.

Costco's shares have risen at an average annual rate of nearly 18% over the past 15 years. We can't assume that will continue -- but it might.

Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses. Speaking at a JPMo

Both stocks deliver above-average yields, but one is definitely safer, and that one might surprise you.

And there could be more positive developments ahead.

AC Immune (NASDAQ:ACIU) reported results from Part 1 of its VacSYn Phase II trial evaluating ACI-7104.056, an active immunotherapy designed to target aggregated alpha-synuclein in early Parkinson’s disease. The placebo-controlled study enrolled 34 participants, with 25 receiving ACI-7104.056 and ni

The chipmaker already pledged up to $10 billion to the Claude maker last year. What would a second check buy?

Nike's fiscal Q1 results may not be enough to boost Nike stock.